Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x10 Supply Disruption — Slate Run Pharmaceuticals (Lo
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x10 Supply Disruption — Slate Run Pharmaceuticals (Lo is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x10; Manufacturer: Slate
| Drug name | Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x10 |
|---|---|
| Manufacturer | Slate Run Pharmaceuticals |
| Recall/Disruption reason | Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weig |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-0343-2026 |
| Initiation date | 20260212 |
| Quantity affected | N/A |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →